Christine J DiDonato
Overview
Explore the profile of Christine J DiDonato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
884
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krosschell K, Brown L, Hoffman K, Zumpf K, Munson H, Bidwell J, et al.
J Neuromuscul Dis
. 2023 Mar;
10(3):337-348.
PMID: 36872785
Background: Ambulatory individuals with spinal muscular atrophy experience weakness and impairments of speed and endurance. This leads to decreased motor skill performance required for daily living including transitioning from floor...
2.
McGrattan K, Graham R, DiDonato C, Darras B
Am J Speech Lang Pathol
. 2021 Apr;
30(3):1008-1022.
PMID: 33822657
Purpose The aim of this study was to provide clinicians with an overview of literature relating to dysphagia in spinal muscular atrophy (SMA) to guide assessment and treatment. Method In...
3.
Ojala K, Reedich E, DiDonato C, Meriney S
Brain Sci
. 2021 Feb;
11(2).
PMID: 33562482
Until the recent development of disease-modifying therapeutics, spinal muscular atrophy (SMA) was considered a devastating neuromuscular disease with a poor prognosis for most affected individuals. Symptoms generally present during early...
4.
Reedich E, Kalski M, Armijo N, Cox G, DiDonato C
Exp Neurol
. 2020 Dec;
337:113587.
PMID: 33382987
Spinal muscular atrophy (SMA) is a pediatric neuromuscular disease caused by genetic deficiency of the survival motor neuron (SMN) protein. Pathological hallmarks of SMA are spinal motor neuron loss and...
5.
Harada Y, Rao V, Arya K, Kuntz N, DiDonato C, Napchan-Pomerantz G, et al.
Muscle Nerve
. 2020 Jul;
62(4):550-554.
PMID: 32710634
Background: Data on combining molecular therapies that increase survival motor neuron protein for spinal muscular atrophy type 1 (SMA1) is lacking. Methods: This was a retrospective study describing our centers'...
6.
Rao V, DiDonato C, Larsen P
Case Rep Neurol Med
. 2018 Aug;
2018:8587203.
PMID: 30159187
Friedreich's ataxia is a neurodegenerative disorder associated with a GAA trinucleotide repeat expansion in intron 1 of the frataxin (FXN) gene. It is the most common autosomal recessive cerebellar ataxia,...
7.
Cherry J, DiDonato C, Androphy E, Calo A, Potter K, Custer S, et al.
PLoS One
. 2017 Sep;
12(9):e0185079.
PMID: 28945765
C5-substituted 2,4-diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS (DAQ-DcpSi) have been developed for the treatment of spinal muscular atrophy (SMA), which is caused by genetic deficiency in the Survival...
8.
Genc B, Jara J, Schultz M, Manuel M, Stanford M, Gautam M, et al.
Ann Clin Transl Neurol
. 2016 May;
3(5):331-45.
PMID: 27231703
Objective: The aim of this study was to investigate the role of ubiquitin C-terminal hydrolase-L1 (UCHL1) for motor neuron circuitry and especially in spinal motor neuron (SMN) health, function, and...
9.
Singh N, Lee B, DiDonato C, Singh R
Future Med Chem
. 2015 Sep;
7(13):1793-808.
PMID: 26381381
Spinal muscular atrophy (SMA) is a major neurodegenerative disorder of children and infants. SMA is primarily caused by low levels of SMN protein owing to deletions or mutations of the...
10.
Heier C, DiDonato C
Front Biosci (Elite Ed)
. 2015 Jan;
7(1):107-16.
PMID: 25553367
Molecular technologies have produced diverse arrays of animal models for studying genetic diseases and potential therapeutics. Many have neonatal phenotypes. Spinal muscular atrophy (SMA) is a neuromuscular disorder primarily affecting...